Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome

Article   Aug 02, 2017 | by Dr. Petra Budde, Head of Medical Research, Protagen and Dr Peter Schulz-Knappe, Chief Scientific Officer, Protagen.

 
Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome
 
 
 

RELATED ARTICLES

X-ray Crystallography: Exploring the Frontiers of Structural Biology

Article

For over a century, X-ray crystallography has enabled scientists to elucidate biological structures in exquisite detail. Now, powerful new technologies are bringing unprecedented opportunities to add to the history of breakthroughs in this cutting-edge field.

READ MORE

Precision Medicine: The Future of Healthcare

Article

As precision medicine holds the key to effective treatment in the future, integrating it with AI and Blockchain technologies can expedite diagnosis and revolutionize the healthcare industry.

READ MORE

Metabolomics: The Long Journey from Lab to Clinic

Article

Recent improvements in technology are enabling the simultaneous detection and quantitation of large numbers of metabolites from biological samples. Here, we examine the challenges and innovations in metabolomics technologies and find out how these tools are impacting on clinical biomarker discovery.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy